Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Lancaster, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Langhorne, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Langhorne, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Reading, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Reading, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Upland, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Upland, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
West Reading, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
West Reading, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Willow Grove, PA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Willow Grove, PA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Hilton Head Island, SC
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Hilton Head Island, SC
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Myrtle Beach, SC
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Nashville, TN
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Bryan, TX
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Bryan, TX
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Abingdon, VA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Abingdon, VA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Lynchburg, VA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Lynchburg, VA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Kennewick, WA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Kennewick, WA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
Clinical Research Facility
mi
from
Spokane, WA
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated:  12/5/2017
mi
from
Hobart,
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)
Status: Enrolling
Updated: 12/5/2017
mi
from
Hobart,
Click here to add this to my saved trials
Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress
Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence
Status: Enrolling
Updated:  12/5/2017
University of Colorado Hospital
mi
from
Aurora, CO
Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress
Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence
Status: Enrolling
Updated: 12/5/2017
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress
Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence
Status: Enrolling
Updated:  12/5/2017
Presbyterian/St. Luke's Medical Center (PSLMC)
mi
from
Denver, CO
Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress
Improved Behavioral Outcome in Allogeneic Hematopoietic Stem Cell Transplant Patients by Reducing Caregiver Distress: Behavioral and Physiological Evidence
Status: Enrolling
Updated: 12/5/2017
Presbyterian/St. Luke's Medical Center (PSLMC)
mi
from
Denver, CO
Click here to add this to my saved trials
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
A Pilot Trial of Platinum, Gemcitabine, or Pemetrexed Single- or Multi-Agent Therapy With Serial Tumor Specimen Collection in Patients With Advanced Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  12/5/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
A Pilot Trial of Platinum, Gemcitabine, or Pemetrexed Single- or Multi-Agent Therapy With Serial Tumor Specimen Collection in Patients With Advanced Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 12/5/2017
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Phase II Trial of Docetaxel and Liposomal Doxorubicin (Doxil) Chemotherapy Combined With Enoxaparin in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated:  12/5/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
Phase II Trial of Docetaxel and Liposomal Doxorubicin (Doxil) Chemotherapy Combined With Enoxaparin in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated: 12/5/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated:  12/5/2017
Norris Cancer Center
mi
from
Los Angeles, CA
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated: 12/5/2017
Norris Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated:  12/5/2017
Bellevue Hospital
mi
from
New York, NY
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated: 12/5/2017
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated:  12/5/2017
NYU Cancer Center
mi
from
New York, NY
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers
A Randomized Phase-II Study of Patients With Locally Advanced Gastric of Gastro-Esophageal Adenocarcinoma Treated With Induction Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Adjuvant Intraperitoneal Floxuridine, Followed by Prolonged Administration of Capecitabine
Status: Enrolling
Updated: 12/5/2017
NYU Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
Phase II Study of Neoadjuvant Treatment With NOV-002 in Combination With Doxorubicin and Cyclophosphamide Followed by Docetaxel in Patients With Stages IIB-IIIC Breast Cancer
Status: Enrolling
Updated:  12/6/2017
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
Phase II Study of Neoadjuvant Treatment With NOV-002 in Combination With Doxorubicin and Cyclophosphamide Followed by Docetaxel in Patients With Stages IIB-IIIC Breast Cancer
Status: Enrolling
Updated: 12/6/2017
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
Phase II Study of Neoadjuvant Treatment With NOV-002 in Combination With Doxorubicin and Cyclophosphamide Followed by Docetaxel in Patients With Stages IIB-IIIC Breast Cancer
Status: Enrolling
Updated:  12/6/2017
University of Miami
mi
from
Miami, FL
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
Phase II Study of Neoadjuvant Treatment With NOV-002 in Combination With Doxorubicin and Cyclophosphamide Followed by Docetaxel in Patients With Stages IIB-IIIC Breast Cancer
Status: Enrolling
Updated: 12/6/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
A Phase I Trial of Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Status: Enrolling
Updated:  12/6/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
A Phase I Trial of Bevacizumab and Temsirolimus in Patients With Advanced Malignancy
Status: Enrolling
Updated: 12/6/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Development of a Blood Test of Anti-IMP3 Autoantibody and Serum MicroRNA Signature for the Detection of Renal Cell Carcinoma With Metastasis and Metastatic Potential
Status: Enrolling
Updated:  12/6/2017
City of Hope Medical Center
mi
from
Duarte, CA
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Development of a Blood Test of Anti-IMP3 Autoantibody and Serum MicroRNA Signature for the Detection of Renal Cell Carcinoma With Metastasis and Metastatic Potential
Status: Enrolling
Updated: 12/6/2017
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
National Jewish Health
mi
from
Denver, CO
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
University of Michigan
mi
from
Ann Arbor, MI
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Henry Ford
mi
from
Detroit, MI
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Henry Ford
mi
from
Detroit, MI
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Ohio State University
mi
from
Columbus, OH
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
University of Toledo Health Science Campus
mi
from
Toledo, OH
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
University of Toledo Health Science Campus
mi
from
Toledo, OH
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Toledo Hospital
mi
from
Toledo, OH
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Medical University of South Carolina
mi
from
Charleston, SC
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Vanderbilt
mi
from
Nashville, TN
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Tennessee Valley Veterans Admin.
mi
from
Nashville, TN
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Tennessee Valley Veterans Admin.
mi
from
Nashville, TN
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated:  12/6/2017
The Mayo Clinic
mi
from
Rochester, MN
Validation of a Multi-gene Test for Lung Cancer Risk
Validation of a Multi-gene Test for Lung Cancer Risk
Status: Enrolling
Updated: 12/6/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Abiraterone Post Ketoconazole for Prostate Cancer
A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole
Status: Enrolling
Updated:  12/6/2017
University of Chicago
mi
from
Chicago, IL
Abiraterone Post Ketoconazole for Prostate Cancer
A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole
Status: Enrolling
Updated: 12/6/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Abiraterone Post Ketoconazole for Prostate Cancer
A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole
Status: Enrolling
Updated:  12/6/2017
University of California at San Francisco
mi
from
San Francisco, CA
Abiraterone Post Ketoconazole for Prostate Cancer
A Phase II Study of Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (CRPC) and Prior Therapy With Ketoconazole
Status: Enrolling
Updated: 12/6/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Arizona Cancer Center at University Medical Center North
mi
from
Tucson, AZ
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Arizona Cancer Center at University Medical Center North
mi
from
Tucson, AZ
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente Deer Valley Medical Center
mi
from
Antioch, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente Deer Valley Medical Center
mi
from
Antioch, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente - Fremont
mi
from
Fremont, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente - Fremont
mi
from
Fremont, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente
mi
from
Fresno, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente
mi
from
Fresno, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente, Hayward
mi
from
Hayward, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente, Hayward
mi
from
Hayward, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente-Modesto
mi
from
Modesto, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente-Modesto
mi
from
Modesto, CA
Click here to add this to my saved trials
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated:  12/6/2017
Kaiser Permanente-Redwood City
mi
from
Redwood City, CA
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Status: Enrolling
Updated: 12/6/2017
Kaiser Permanente-Redwood City
mi
from
Redwood City, CA
Click here to add this to my saved trials